Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort

Launched by NANFANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY · Jun 3, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the long-term outcomes for patients diagnosed with duodenal adenocarcinoma (DA), a type of cancer that affects the upper part of the small intestine. The researchers want to understand how different factors, such as the tumor's characteristics and the treatments patients receive, affect their chances of survival over time. The study will gather information from a large group of patients, based on 15 years of experience at the hospital.

To participate in the trial, individuals must be between the ages of 65 and 74 and have a confirmed diagnosis of non-ampullary duodenal adenocarcinoma. Unfortunately, those who have other types of gastrointestinal cancer, incomplete medical records, or who do not want to share their clinical information will not be eligible. Although the trial is not yet recruiting participants, those who join can expect to provide details about their health history and treatment, helping researchers gain valuable insights into this rare cancer.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • (1) histologically confirmed non-ampulla DA;
• Exclusion criteria:
• • 1. had other gastrointestinal cancer;
• • 2. had incomplete medical records, or lost follow-up shortly after diagnosis;
• • 3. refused clinical data collection.